This article explores current health trends, including the rise of popular clinics, the debate around weight loss jabs, dietary changes by a dietitian, and direct sales of obesity drugs. Read more...

Frankfurt is buzzing with activity! From Ramadan lights downtown to a unique craft beer and Indian food fusion, and the return of Goethe to the Städel, there's something for everyone. Read more...

Novo Nordisk and Eli Lilly are battling it out in the weight-loss drug market with price cuts on Wegovy and Zepbound. Also, investment firms adjust their positions in KKR and Blue Owl. Read more...

Explore curated lists from BuzzFeed: cleaning tips from clean freaks, affordable beauty finds, must-have kitchen gadgets, impressive product transformations, and bizarre architectural designs. Read more...

A look at the latest political headlines, including tensions in the Ukraine war, forensic investigations into past cases, and financial concerns for the Vatican and infrastructure projects. Read more...

Recent business news covers mortgage implications after house destruction, wealth-building strategies, prescription drug price cuts, and the rise and fall of Forever 21. Read more...

Recent speculation surrounds Ariana Grande potentially starring in an Audrey Hepburn biopic. The article also explores her recent fashion choices and other projects. Read more...

Eli Lilly and Nvidia are experiencing positive momentum, with Lilly's stock rising after an analyst upgrade and Nvidia showcasing impressive Q4 earnings. Both companies are key players in shaping the future of healthcare and technology. Read more...

This article covers a range of topics, from DIY kitchen upgrades and expert baking tips using Walmart finds, to warnings about hidden cameras in Airbnbs and car buying advice. Read more...

Investors face a potentially volatile Friday with a key jobs report and Powell's speech looming. Concerns also rise as U.S. layoffs hit a post-pandemic high, while Hims & Hers stock suffers a sharp decline. Read more...

Recent analyst reports show positive momentum for YETI, ON Semiconductor, and Eli Lilly, with raised price targets and continued "overweight" ratings. Plus, a look at Caterpillar as a potential dividend stock. Read more...